Analyst Group

Analyst Group Comment on NMD’s Decision to Bring Forward the Launch of Nozoil and Place an Additional Order

Källa: MFN
Neutral

Sammanfattning

Norsk Medisinaldepot (NMD) påskyndar lanseringen av Nozoil i Norge till 1 juni och lägger en tilläggsorder värd 160 TSEK. Den totala orderstocken uppgår nu till cirka 400 TSEK. Den snabbare lanseringen beror på stark efterfrågan hos apotekskedjorna Vitus och Ditt apotek.

Analys

Pressmeddelandet indikerar en stark efterfrågan på Nozoil i Norge, vilket leder till en tidigarelagd lansering och en ytterligare order. Den totala orderstorleken är dock relativt liten (400 TSEK) i förhållande till ett noterat bolag. Den ökade efterfrågan och snabbare lansering är positivt, men den materiella effekten på bolagets finansiella resultat är begränsad givet orderstorleken.

Nyckeltal

Tilläggsorder
160 TSEK
Total orderstock
ca 400 TSEK

Insikter

  • • Den tidiga lanseringen och tilläggsordern tyder på en positiv marknadsmottagning i Norge.
  • • Orderstorleken är begränsad och påverkar sannolikt inte bolagets finansiella resultat nämnvärt på kort sikt.

Nosa Plugs AB (”Nosa Plugs” or ”the Company”) announced on 28 May 2026 that Norwegian pharmaceutical wholesaler Norsk Medisinaldepot (”NMD”), which recently added Nozoil to its portfolio for distribution on the Norwegian pharmacy market, is bringing forward its pharmacy launch to 1 June. In connection with the launch, NMD has placed an additional order of SEK 160 TSEK, bringing the combined value of both orders to approximately SEK 400 TSEK. The reason for the accelerated timeline is that Vitus apotek and Ditt apotek are already seeing strong demand for Nozoil and are beginning to sell the product in stores and online as of today, Thursday 28 May. Vitus apotek and Ditt apotek together comprise approximately 550 pharmacies, covering a majority of Norwegian pharmacies. Nozoil is also available through Apotera.

Nosa Plugs AB (”Nosa Plugs” or ”the Company”) announced on 28 May 2026 that Norwegian pharmaceutical wholesaler Norsk Medisinaldepot (”NMD”), which recently added Nozoil to its portfolio for distribution on the Norwegian pharmacy market, is bringing forward its pharmacy launch to 1 June. In connection with the launch, NMD has placed an additional order of SEK 160 TSEK, bringing the combined value of both orders to approximately SEK 400 TSEK. The reason for the accelerated timeline is that Vitus apotek and Ditt apotek are already seeing strong demand for Nozoil and are beginning to sell the product in stores and online as of today, Thursday 28 May. Vitus apotek and Ditt apotek together comprise approximately 550 pharmacies, covering a majority of Norwegian pharmacies. Nozoil is also available through Apotera.

Read Analyst Group’s comment here

About Analyst Group: One of Sweden's leading equity research boutiques with focus on small and medium-sized listed companies.Read more about Analyst Group This is a press release from Analyst Group regarding the publication of a comment on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the comment. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.